A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/416 (2006.01) A61K 31/00 (2006.01) A61K 31/4745 (2006.01) A61K 31/519 (2006.01)
Patent
CA 2478918
A method for treating an angiogenesis-related disorder. The method includes administrating to a subject in need thereof an effective amount of a compound of the formula (I): Each of Ar1, Ar2, and Ar3, independently, is phenyl, thienyl, furyl, pyrrolyl, pyridinyl, or pyrimidinyl; each of R1, R2, R3, R4, R5, and R6, independently, is R, nitro, halogen, C(O)OR, C(O)SR, C(O)NRR', (CH2)mOR, (CH2)mSR, (CH2)mNRR', (CH2)mCN, (CH2)mC(O)OR, (CH2)mCHO, (CH2)mCH=NOR, or R1 and R2 together, R3 and R4 together, or R5 and R6 together are O(CH2)mO, in which each of R and R', independently, is H or C1.sim.C6 alkyl; and m is 0, 1, 2, 3, 4, 5, or 6, and n is 0, 1, 2, or 3.
L'invention porte sur un procédé de traitement d'une maladie relative à l'angiogenèse. Ce procédé consiste à administrer à un sujet une quantité effective d'un composé de formule (I): chacun de Ar¿1?, Ar¿2? et Ar¿3?, indépendamment, représente phényle, thiényle, furyle, pyrrolyle, pyridinyle ou pyrimidinyle; chacun de R¿1?, R¿2?, R¿3?, R¿4?, R¿5? et R¿6?, indépendamment, représente R, nitro, halogène, C(O)OR, C(O)SR, C(O)NRR', (CH¿2?)¿m?OR, (CH¿2?)¿m?SR, (CH¿2?)¿m?NRR', (CH¿2?)¿m?CN, (CH¿2?)¿m?C(O)OR, (CH¿2?)¿m?CHO, (CH¿2?)¿m?CH=NOR, ou bien R¿1? et R¿2? réunis, R¿3? et R¿4 ?réunis ou R¿5? et R¿6 ?réunis représentent O(CH¿2?)¿m?O, chacun de R et R', indépendamment, représentant H ou C¿1?~C¿6? alkyle; et m représente 0, 1, 2, 3, 4, 5 ou 6 et n représente 0, 1, 2, or 3.
Guh Jih-Hwa
Kuo Shen-Chu
Pan Shiow-Lin
Teng Che-Ming
Yu Lee Fang
Carlsbad Technology Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Angiogenesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiogenesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenesis inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2091803